Travere Therapeutics Inc (TVTX) — Cash Flow Reinvestment Rate
Travere Therapeutics Inc (TVTX) has a Cash Flow Reinvestment Rate of 1.42x as of December 2025, reinvesting $85.88 Million (capex $375.00K plus investments $-85.50 Million) from operating cash flow of $60.68 Million. See Travere Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Travere Therapeutics Inc Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Travere Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see TVTX cash flow conversion.
Annual Cash Flow Reinvestment Rate for Travere Therapeutics Inc (2017–2025)
Year-by-year capital reinvestment analysis for Travere Therapeutics Inc. See Travere Therapeutics Inc (TVTX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.83x | $144.61 Million | $37.78 Million | $58.16 Million | ▲ +8.5% |
| 2017 | 3.53x | $26.12 Million | $7.40 Million | $14.01 Million | — |